The FDA has launched a pilot program involving oncology drug products and in vitro diagnostic tests that is intended to help clinicians select appropriate cancer treatments for patients. The agency said that the pilot program “may be helpful in reducing the risk of using [laboratory developed tests (LDTs)] for oncology drug treatment decisions” while the FDA continues to work ... Read More